Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model.

Kuppen PJ, Gorter A, Hagenaars M, Jonges LE, Giezeman-Smits KM, Nagelkerke JF, Fleuren G, van de Velde CJ.

Immunol Rev. 2001 Dec;184:236-43. Review.

PMID:
12086316
2.

Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1).

Brissette-Storkus CS, Kettel JC, Whitham TF, Giezeman-Smits KM, Villa LA, Potter DM, Chambers WH.

J Leukoc Biol. 2002 Jun;71(6):941-9.

PMID:
12050178
3.

Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.

Okada H, Attanucci J, Giezeman-Smits KM, Brissette-Storkus C, Fellows WK, Gambotto A, Pollack LF, Pogue-Geile K, Lotze MT, Bozik ME, Chambers WH.

Cancer Res. 2001 Mar 15;61(6):2625-31.

4.

NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis.

Jonges LE, Giezeman-Smits KM, van Vlierberghe RL, Ensink NG, Hagenaars M, Joly E, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ.

Immunobiology. 2000 Nov;202(4):326-38.

PMID:
11131150
5.

Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.

Cancer Res. 2000 May 1;60(9):2449-57.

6.

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.

Okada H, Giezeman-Smits KM, Tahara H, Attanucci J, Fellows WK, Lotze MT, Chambers WH, Bozik ME.

Gene Ther. 1999 Feb;6(2):219-26.

7.

The regulatory role of CD45 on rat NK cells in target cell lysis.

Giezeman-Smits KM, Gorter A, van Vlierberghe RL, v Eendenburg JD, Eggermont AM, Fleuren GJ, Kuppen PJ.

J Immunol. 1999 Jul 1;163(1):71-6.

8.

Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.

Okada H, Tahara H, Shurin MR, Attanucci J, Giezeman-Smits KM, Fellows WK, Lotze MT, Chambers WH, Bozik ME.

Int J Cancer. 1998 Oct 5;78(2):196-201.

9.

Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL-2-activated rat NK cells.

Giezeman-Smits KM, Jonges LE, Chambers WH, Brisette-Storkus CS, Van Vlierberghe RL, Van Eendenburg JD, Eggermont AM, Fleuren GJ, Kuppen PJ.

J Leukoc Biol. 1998 Feb;63(2):209-15.

PMID:
9468279
10.

Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery.

Giezeman-Smits KM, Gorter A, Nagelkerke JF, van Vlierberghe RL, van Eendenburg J, Eggermont AM, Fleuren GJ, Kuppen PJ.

Immunobiology. 1997 Nov;197(5):429-43.

PMID:
9413744
11.

The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells.

Giezeman-Smits KM, Kuppen PJ, Ensink NG, Eggermont AM, Stals F, Wonigeit K, Fleuren GJ.

Immunobiology. 1996 Aug;195(3):286-99.

PMID:
8877403

Supplemental Content

Loading ...
Support Center